Authors
Latest:
Opportunities and Challenges: A Time to Reflect at the End of a Busy YearIt is the final month of what has been economically a very tough year. Oncology centers and practices continue to face declining reimbursements on all service lines, and most have had either flat or lower revenues.
Latest:
TechSectors: Connectivity: Improving Physician-Patient CommunicationMore than ever before, healthcare professionals are strapped for time.
Latest:
Did Wernicke Really Postulate Only Two Language Centers?It is not much of a stretch to say that our modern accounts of the functional anatomy of language are relatively minor tweaks to Wernicke's model.
Latest:
Management of multivessel CAD in ACS patients: Do not leave for later what you can finish todayAlthough multivessel coronary artery disease (CAD) is commonly encountered in patients with acute coronary syndrome (ACS), no randomized controlled trials have evaluated the effi cacy of singlevessel percutaneous coronary intervention (PCI) versus multivessel PCI.
Latest:
The vegetarian paradox: Low HDL cholesterol levels and low cardiovascular riskEver since the observation in the 1950s that high-density lipoprotein (HDL) cholesterol was inversely correlated with coronary artery disease, there have been confounding data that have not been reconciled.
Latest:
Hospital Variation in Use of Noninvasive Cardiac ImagingExploring the benefits of routine use of noninvasive cardiac testing for patients with suspected coronary ischemia.
Latest:
Community-acquired MRSA pericarditisOnly 2 cases of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) pericarditis have been reported in the English literature. Over the last 15 years, CA-MRSA has emerged as an increasingly common pathogen that is genetically and epidemiologically different from hospital-acquired MRSA (HA-MRSA).
Latest:
First Gluten Exposure and the Likelihood of Celiac DiseaseThis was a prospective multinational birth cohort study to determine if the age of first gluten introduction was associated with increased risk for celiac disease in genetically predisposed (high risk) children.
Latest:
Cofactors and Concerns in FCS TreatmentsAbhimanyu Garg, MD, discusses the cofactors and concerns in FCS treatments.
